We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.

Sandbox 7784

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (19:12, 18 June 2017) (edit) (undo)
 
(2 intermediate revisions not shown.)
Line 6: Line 6:
Tacrine was the first cholinesterase inhibitor approved for the treatment of Alzheimer's disease.
Tacrine was the first cholinesterase inhibitor approved for the treatment of Alzheimer's disease.
-
Tacrine’s ringed structure is stacked between the <scene name='76/761691/Tacrine/1'>aromatic rings of Trp84 and Phe330</scene>.
+
Tacrine’s ringed structure is stacked between the <scene name='76/761691/Tacrine/2'>aromatic rings of Trp84 and Phe330</scene><ref>PMID:8415649</ref>.
-
 
+
-
*Harel et al Silman & Sussman (1993) "Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase" PNAS, 90, 9031-5.
+
-
.
+
</StructureSection>
</StructureSection>
 +
==References==
 +
<references/>

Current revision

Your Heading Here (maybe something like 'Structure')

Escherichia coli reca protein-bound DNA (PDB entry 1acj)

Drag the structure with the mouse to rotate

References

  1. ↑ Harel M, Schalk I, Ehret-Sabatier L, Bouet F, Goeldner M, Hirth C, Axelsen PH, Silman I, Sussman JL. Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase. Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):9031-5. PMID:8415649
Retrieved from "http://52.214.119.220/wiki/index.php/Sandbox_7784"
Personal tools